Effect of Ascorbic Acid Supplementation in Pregnancy on Anemia (AAA)
Launched by FETAL MEDICINE FOUNDATION · Jun 19, 2018
Trial Information
Current as of August 23, 2025
Withdrawn
Keywords
ClinConnect Summary
A. Anemia is the most common hematological abnormality during pregnancy and was found to affect 24.1% of pregnant women in a WHO study.2 The most common types of anemia affecting pregnancy are iron-deficiency and acute blood loss. Vitamin C, also known as ascorbic acid, has been well documented to play an active role in the absorption and metabolism of iron from the gut.6 Vitamin C has been used in studies to treat anemic non-pregnant women resulting in significant increases in hemoglobin levels. Similar effects have been found in multiple studies using vitamin C as adjunct treatment for he...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • gestational age at enrollment less than 20 0/7 weeks,
- • singleton gestation,
- • iron deficiency anemia defined as maternal serum ferritin levels less than 15 micrograms/dL, and
- • planned delivery at Miami Valley Hospital.
- Exclusion Criteria:
- • vitamin C use \>150mg/day (typical prenatal vitamin contains 60mg Vitamin C),
- • diabetes (gestational, types 1,2); chronic medical disease;
- • known or discovered hemoglobinopathy (including heterozygous states);
- • known metabolic disease that may contribute to impaired iron absorption (including a history of bariatric surgery, renal disease and an inability to tolerate oral iron);
- • known fetal abnormalities;
- • participation in another interventional trial;
- • illicit drug or alcohol use
About Fetal Medicine Foundation
The Fetal Medicine Foundation (FMF) is a leading international organization dedicated to advancing research and education in fetal medicine. Established to improve prenatal care and outcomes, FMF focuses on innovative clinical trials that explore the diagnosis and management of fetal conditions. By fostering collaboration among healthcare professionals and leveraging cutting-edge technologies, the foundation aims to enhance the understanding of fetal development and improve interventions for expectant mothers. With a commitment to ethical standards and patient-centered research, FMF plays a pivotal role in shaping the future of fetal medicine and improving the health of mothers and their unborn children.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dayton, Ohio, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials